Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Olfactory transduction | R-HSA-9751605 | map04740 | syrosingopine | 19518 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | syrosingopine | 19518 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | syrosingopine | 19518 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | syrosingopine | 19518 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | syrosingopine | 19518 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | syrosingopine | 19518 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | syrosingopine | 19518 | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | syrosingopine | 19518 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | syrosingopine | 19518 | drug-path |
Melanogenesis | R-HSA-5662702 | map04916 | ellipticine | 3052 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | ellipticine | 3052 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | ellipticine | 3052 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | ellipticine | 3052 | drug-path |
PPAR signaling pathway | R-HSA-168638 | map03320 | ellipticine | 3052 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | ellipticine | 3052 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ellipticine | 3052 | drug-path |
Taste transduction | R-HSA-162582 | map04742 | ellipticine | 3052 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | ellipticine | 3052 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | ellipticine | 3052 | drug-path |
Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | ellipticine | 3052 | drug-path |